In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats

Prostaglandins Leukot Essent Fatty Acids. 1992 Nov;47(3):183-6. doi: 10.1016/0952-3278(92)90236-c.

Abstract

To investigate the blood pressure lowering effect of magnesium (Mg2+) in the hypertensive rat, we measured the prostacyclin release (PGI2, as immunoreactive 6-keto-PGF1 alpha) by isolated aortae from normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive rats fed a control or Mg(2+)-enriched diet. We also studied the in vitro effect of Mg2+ on aortic PGI2 release. The Mg(2+)-enriched diet significantly decreased by 10% blood pressure in DOCA-salt hypertensive rats but not in normotensive rats. The Mg(2+)-enriched diet significantly increased by 122% aortic PGI2 release in DOCA-salt hypertensive rats, but not in normotensive rats. Mg2+ supplementation in the incubation medium (4.8 mM) significantly increased aortic PGI2 release by 94% in DOCA-salt hypertensive rats, but not in normotensive rats. These data suggest that the Mg(2+)-induced attenuation of blood pressure in DOCA-salt hypertensive rats could be linked with the enhanced vascular PGI2 release.

MeSH terms

  • Animals
  • Aorta / drug effects*
  • Aorta / metabolism
  • Blood Pressure / drug effects
  • Desoxycorticosterone
  • Epoprostenol / biosynthesis*
  • Epoprostenol / metabolism
  • Hypertension / chemically induced
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • In Vitro Techniques
  • Magnesium / pharmacology*
  • Male
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Desoxycorticosterone
  • Epoprostenol
  • Magnesium